Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1952 1
1954 1
1962 1
1967 1
1968 1
1969 2
1970 1
1971 1
1972 1
1978 4
1981 5
1982 3
1983 9
1984 13
1985 7
1986 7
1987 14
1988 3
1989 5
1990 12
1991 13
1992 5
1993 11
1994 6
1995 10
1996 6
1997 6
1998 8
1999 12
2000 6
2001 7
2002 8
2003 17
2004 19
2005 13
2006 17
2007 57
2008 48
2009 46
2010 46
2011 27
2012 24
2013 31
2014 30
2015 33
2016 33
2017 27
2018 38
2019 29
2020 39
2021 37
2022 33
2023 32
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

775 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. Among authors: petrini m. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
The Renewal of Cancer Immunotherapy.
Bulgarelli J, Pignatta S, Petrini M, Ridolfi L. Bulgarelli J, et al. Among authors: petrini m. Vaccines (Basel). 2023 Mar 4;11(3):592. doi: 10.3390/vaccines11030592. Vaccines (Basel). 2023. PMID: 36992176 Free PMC article.
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D. Cornely OA, et al. Among authors: petrini m. N Engl J Med. 2007 Jan 25;356(4):348-59. doi: 10.1056/NEJMoa061094. N Engl J Med. 2007. PMID: 17251531 Free article. Clinical Trial.
Gliptins.
Focosi D, Kast RE, Petrini M. Focosi D, et al. Among authors: petrini m. Lancet. 2007 Jan 27;369(9558):269-70. doi: 10.1016/S0140-6736(07)60137-8. Lancet. 2007. PMID: 17258656 No abstract available.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Gini G, Tani M, Tucci A, Marcheselli L, Cesaretti M, Bellei M, Pascarella A, Ballerini F, Petrini M, Merli F, Olivieri A, Lanza F, Annibali O, Zilioli VR, Liberati AM, Tisi MC, Arcari A, Marino D, Musuraca G, Pavone V, Fabbri A, Pozzi S, Mannina D, Plenteda C, Celli M, Luminari S. Gini G, et al. Among authors: petrini m. Blood. 2023 Oct 26;142(17):1438-1447. doi: 10.1182/blood.2022019173. Blood. 2023. PMID: 37418685 Free article. Clinical Trial.
Editorial: In Search of In vivo MSC.
Pacini S, Petrini M. Pacini S, et al. Among authors: petrini m. Front Cell Dev Biol. 2017 May 29;5:60. doi: 10.3389/fcell.2017.00060. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 28611984 Free PMC article. No abstract available.
Piezoelectric Signals in Vascularized Bone Regeneration.
D'Alessandro D, Ricci C, Milazzo M, Strangis G, Forli F, Buda G, Petrini M, Berrettini S, Uddin MJ, Danti S, Parchi P. D'Alessandro D, et al. Among authors: petrini m. Biomolecules. 2021 Nov 20;11(11):1731. doi: 10.3390/biom11111731. Biomolecules. 2021. PMID: 34827729 Free PMC article. Review.
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Bachy E, Savage KJ, Huang H, Kwong YL, Gritti G, Zhang Q, Liberati AM, Cao J, Yang H, Hao S, Hu J, Zhou K, Petrini M, Russo F, Zhang H, Sang W, Ji J, Ferreri AJM, Damaj GL, Liu H, Zhang W, Ke X, Ghiggi C, Huang S, Li X, Yao H, Paik J, Novotny W, Zhou W, Zhu H, Zinzani PL. Bachy E, et al. Among authors: petrini m. Blood Adv. 2023 Aug 22;7(16):4435-4447. doi: 10.1182/bloodadvances.2022009575. Blood Adv. 2023. PMID: 37276067 Free PMC article. Clinical Trial.
Progressive multifocal leukoencephalopathy: what's new?
Focosi D, Marco T, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M. Focosi D, et al. Among authors: petrini m. Neuroscientist. 2010 Jun;16(3):308-23. doi: 10.1177/1073858409356594. Neuroscientist. 2010. PMID: 20479473 Review.
775 results